Comparison of adjunctive ropinirole 24-hour prolonged release and ropinirole immediate release in patients with advanced Parkinson's disease: A per-protocol analysis of the PREPARED study

被引：0

|

作者：

Schapira, A. H. V.

Stocchi, F.

Hunter, B.

Giorgi, L.

机构：

来源：

MOVEMENT DISORDERS | 2008年 / 23卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

594

引用

收藏

页码：S196 / S197

页数：2

相关论文

共 50 条

[21] 24-Hour Symptom Control with Ropinirole Prolonged Release in Patients with Advanced Parkinson's Disease Not Optimally Controlled with L-Dopa
Stocchi, Fabrizio
Rolfe, Katie
Cooper, James
Lipschitz, Alan
NEUROLOGY, 2010, 74 (09) : A393 - A394
[22] Adjunctive ropinirole 24-hour prolonged release improves the patient-reported outcomes of sleep and quality of life in advanced Parkinson's disease (PD)
Giorgi, L.
Hunter, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 113 - 113
[23] Ropinirole prolonged release offers patients with advanced Parkinson's disease greater opportunity to reduce their daily "off" time than ropinirole immediate release
Stocchi, F.
Giorgi, L.
Hunter, B.
Statham, J.
Schapira, A. H. V.
MOVEMENT DISORDERS, 2009, 24 : S280 - S280
[24] Ropinirole 24-hour prolonged-release adjunctive therapy improves cardinal symptoms in patients with advanced Parkinson's disease not optimally controlled with L-dopa
Isaacson, S.
Pahwa, R.
Earl, N.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S108 - S108
[25] Adjunctive ropinirole 24-hour prolonged release reduces "Off" time and improves the cardinal symptoms of tremor, rigidity, and bradykinesia in patients with advanced Parkinson's disease (PD)
Pahwa, R.
Stover, N.
Earl, N.
MOVEMENT DISORDERS, 2007, 22 (12) : X - X
[26] Ropinirole 24-hour prolonged release improves sleep disturbance, but does not increase daytime somnolence in patients with advanced Parkinson's disease when administered as adjunctive therapy
Isaacson, S.
Stocchi, F.
Earl, N.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S108 - S108
[27] Relationship between awake time spent "off" and systemic exposure of ropinirole 24-hour prolonged release in patients with advanced Parkinson's disease
Tompson, D.
Pahwa, R.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S109 - S109
[28] Ropinirole 24-hour prolonged release provides efficacy as early as Week 2 when used as adjunctive therapy to L-dopa in patients with advanced Parkinson's disease
Pahwa, R.
Stacy, M. A.
Elmer, L. W.
Isaacson, S. H.
MOVEMENT DISORDERS, 2006, 21 : S595 - S595
[29] Ropinirole 24-hour prolonged release improves disease-specific and global symptoms when used as adjunctive therapy to L-dopa in patients with advanced Parkinson's disease
Sethi, K. D.
Hauser, R. A.
Earl, N. L.
MOVEMENT DISORDERS, 2006, 21 : S570 - S570
[30] Ropinirole 24-hour prolonged release reduces "off" time and the dose of L-dopa needed when used as adjunctive therapy in patients with advanced Parkinson's disease
Stacy, M. A.
Pahwa, R.
Earl, N. L.
MOVEMENT DISORDERS, 2006, 21 : S596 - S596

← 1 2 3 4 5 →